Brand family
Ery-Ped
Erythromycin · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
United States
- Presentations
- 2
- Markets
- 1
Ery-Ped is a brand of Erythromycin marketed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Erythromycin
- Brand owner
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Registered in
- United States
- Strengths and forms
- 200 mg/5 mL oral suspension, 400 mg/5 mL oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ery-Ped 200 mg/5 mL oral suspensionOral | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | US FDA | Available on request |
| Ery-Ped 400 mg/5 mL oral suspensionOral | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | US FDA | Available on request |
Equivalent brands
Other brands of Erythromycin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ery-Ped
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.